Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Maintains Buy on Plexus, Raises Price Target to $105

Needham Maintains Buy on Plexus, Raises Price Target to $105

Needham analyst James Ricchiuti maintains Plexus (NASDAQ:PLXS) with a Buy and raises the price target from $93 to $105.

byBenzinga Newsdesk

July 29, 2022

1 minute read

Needham analyst James Ricchiuti maintains Plexus (NASDAQ:PLXS) with a Buy and raises the price target from $93 to $105.

What Does IDEXX Laboratories’ Debt Look Like?

By Benzinga Insights

April 28, 10:46 AM

Over the past three months, shares of IDEXX Laboratories Inc. (NASDAQ:IDXX) increased by 2.13%. Before having a look…

IDXX

China’s Most Indebted Property Developer Loses $2B Value After Shares Resumed Trading

By Lekha Gupta

August 28, 6:52 AM

Property developer, China Evergrande Group (OTC: EGRNF) disclosed

EGRNF

Hurco Companies’ Board Approved Additional Share Repurchase Program In An Aggregate Amount Of Up To $25M

By Benzinga Newsdesk

January 6, 9:09 AM

Effective as of January 4, 2023, Hurco Companies, Inc. (the “Company”), Bank of America, N.A. (the “Lender”), and certain wholly-owned subsidiaries of the Company (the “Loan Party

HURC

Magnificent 7 Eye $13-Trillion Market Cap: ‘They Are Sucking All The Air Out Of The Universe,’ Wall Street Veteran Says

By Piero Cingari

February 5, 5:13 PM

Magnificent Seven market value surpasses $13 trillion, causing concerns about concentration in equity indices and investment portfolios.

AAPL

Needham Maintains Buy on Plexus, Raises Price Target to $105

Related Posts

What Does IDEXX Laboratories’ Debt Look Like?

China’s Most Indebted Property Developer Loses $2B Value After Shares Resumed Trading

Hurco Companies’ Board Approved Additional Share Repurchase Program In An Aggregate Amount Of Up To $25M

Magnificent 7 Eye $13-Trillion Market Cap: ‘They Are Sucking All The Air Out Of The Universe,’ Wall Street Veteran Says